Paying users zone. Data is covered by 
.
Get 1 month access to Thermo Fisher Scientific Inc. for $19.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Thermo Fisher Scientific Inc. (TMO)
Profitability Analysis
Difficulty: Beginner
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Ratios (Summary)
Thermo Fisher Scientific Inc., profitability ratios
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Thermo Fisher Scientific Inc.’s gross profit margin deteriorated from 2016 to 2017 and from 2017 to 2018. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Thermo Fisher Scientific Inc.’s operating profit margin improved from 2016 to 2017 and from 2017 to 2018. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Thermo Fisher Scientific Inc.’s net profit margin deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Thermo Fisher Scientific Inc.’s ROE deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Thermo Fisher Scientific Inc.’s ROA deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Gross Profit Margin
Thermo Fisher Scientific Inc., gross profit margin calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Gross profit | |
|
|
|
|
|
| Revenues | |
|
|
|
|
|
| Ratio | ||||||
| Gross profit margin1 | |
|
|
|
|
|
| Benchmarks | ||||||
| Gross Profit Margin, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenues
= 100 × ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Thermo Fisher Scientific Inc.’s gross profit margin deteriorated from 2016 to 2017 and from 2017 to 2018. |
Operating Profit Margin
Thermo Fisher Scientific Inc., operating profit margin calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Operating income | |
|
|
|
|
|
| Revenues | |
|
|
|
|
|
| Ratio | ||||||
| Operating profit margin1 | |
|
|
|
|
|
| Benchmarks | ||||||
| Operating Profit Margin, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| Operating Profit Margin, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| Operating Profit Margin, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
Operating profit margin = 100 × Operating income ÷ Revenues
= 100 × ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Thermo Fisher Scientific Inc.’s operating profit margin improved from 2016 to 2017 and from 2017 to 2018. |
Net Profit Margin
Thermo Fisher Scientific Inc., net profit margin calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income | |
|
|
|
|
|
| Revenues | |
|
|
|
|
|
| Ratio | ||||||
| Net profit margin1 | |
|
|
|
|
|
| Benchmarks | ||||||
| Net Profit Margin, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| Net Profit Margin, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| Net Profit Margin, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
Net profit margin = 100 × Net income ÷ Revenues
= 100 × ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Thermo Fisher Scientific Inc.’s net profit margin deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Return on Equity (ROE)
Thermo Fisher Scientific Inc., ROE calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income | |
|
|
|
|
|
| Shareholders’ equity | |
|
|
|
|
|
| Ratio | ||||||
| ROE1 | |
|
|
|
|
|
| Benchmarks | ||||||
| ROE, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| ROE, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| ROE, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
ROE = 100 × Net income ÷ Shareholders’ equity
= 100 × ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Thermo Fisher Scientific Inc.’s ROE deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Return on Assets (ROA)
Thermo Fisher Scientific Inc., ROA calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income | |
|
|
|
|
|
| Total assets | |
|
|
|
|
|
| Ratio | ||||||
| ROA1 | |
|
|
|
|
|
| Benchmarks | ||||||
| ROA, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| ROA, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| ROA, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Thermo Fisher Scientific Inc.’s ROA deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |